Download PDF
Synlett 2010(8): 1281-1284  
DOI: 10.1055/s-0029-1219800
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Unexpected and Divergent Reactions of N-Formyl-1,2-dihydroquinolines with Sodium Azide: Highly Chemoselective Formation of 2-Substituted Quinolines and Isoxazolo[4,3-c]quinolines

Weike Su*, Jingbo Yu, Zhenhua Li, Bei Zheng
Key Laboratory of Pharmaceutical Engineering of Ministry of Education, College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, P. R. of China
Fax: +86(571)88320752; e-Mail: pharmlab@zjut.edu.cn;
Further Information

Publication History

Received 22 January 2010
Publication Date:
25 March 2010 (online)

    Permissions and Reprints All articles of this category

Abstract

Efficient and divergent synthesis of 2-substituted quinolines and isoxazolo[4,3-c]quinolines was achieved from N-formyl-1,2-dihydroquinolines with the aid of sodium azide. The synthesis is substituent-dependent. Thus N-formyl-1,2-dihydroquinolines with a hydrogen atom at the 3-position afforded 2-substituted quinolines in good to excellent yields, while with a 3-formyl group, N-formyl-1,2-dihydroquinolines unexpectedly gave isoxazolo[4,3-c]quinolines in high yields.

Key words

azides - quinolines - chemoselectivity - deformylation heterocycles

    References and Notes

  • 1a Kleeman A. Engel J. Kutscher B. Reichert D. Pharmaceutical Substances, Synthesis, Patents, Applications   Thieme; Stuttgart, New York: 2001. 
    Google Scholar
  • 1b Michael JP. Nat. Prod. Rep.  2001,  18:  543 
    Google Scholar
  • 1c Funayama S. Murata K. Noshita T. Heterocycles  2001,  54:  1139 
    Google Scholar
  • 2 Huang LJ. Hsieh MC. Teng CM. Lee KH. Kuo SC. Bioorg. Med. Chem.  1998,  6:  1657 
    CrossrefGoogle Scholar
  • 3 Musser JH. Chakraborty UR. Sciortino S. Gordon RJ. Khandwala A. Neiss ES. Pruss TP. Van Inwegen R. Weinryb I. Coutts SM. J. Med. Chem.  1987,  30:  96 
    CrossrefGoogle Scholar
  • 4 Gauthier JY. Jones T. Champion E. Charette L. Dehaven R. Ford-Hutchinson AW. Hoogsteen K. Lord A. Masson P. Piechuta H. Pong SS. Springer JP. Therien M. Zamboni R. Young RN. J. Med. Chem.  1990,  33:  2841 
    CrossrefPubMedGoogle Scholar
  • For example:
  • 5a Majumder S. Gipson KR. Odom AL. Org. Lett.  2009,  11:  4720 
    Google Scholar
  • 5b Martinez R. Ramon DJ. Yus M. J. Org. Chem.  2008,  73:  9778 
    Google Scholar
  • 5c Schramm OG. Oeser T. Kaiser M. Brun R. Müller TJJ. Synlett  2008,  359 
    Google Scholar
  • 5d Zhang ZH. Tan JJ. Wang ZY. Org. Lett.  2008,  10:  173 
    Google Scholar
  • 5e Horn J. Marsden SP. Nelson A. House D. Weingarten GG. Org. Lett.  2008,  10:  4117 
    Google Scholar
  • 5f Li L. Jones WD. J. Am. Chem. Soc.  2007,  129:  10707 
    Google Scholar
  • 5g Sandelier MJ. DeShong P. Org. Lett.  2007,  9:  3209 
    Google Scholar
  • 6 Li H. Zheng C. Chen RE. Su WK. Org. Prep. Proced. Int.  2009,  41:  156 
    CrossrefGoogle Scholar
  • 7a Wolf C. Lerebours R. J. Org. Chem.  2003,  68:  7077 
    Google Scholar
  • 7b Pierce AC. ter Haar E. Binch HM. Kay DP. Patel SR. Li P. J. Med. Chem.  2005,  48:  1278 
    Google Scholar
  • 7c Andersen KE. Lundt BF. Jorgensen AS. Braestrup C. Eur. J. Med. Chem.  1996,  31:  417 
    Google Scholar
  • 7d Holla BS. Mahalinga M. Karthikeyan MS. Poojary B. Akberali PM. Kumari NS. Eur. J. Med. Chem.  2005,  40:  1173 
    Google Scholar
  • 7e Zhong BY. Al-Awar RS. Shih C. Grimes JH. Vieth M. Hamdouchi C. Tetrahedron Lett.  2006,  47:  2161 
    Google Scholar
  • 7f Lim J. Stock N. Pracitto R. Boueres JK. Munoz B. Chaudhary A. Santini AM. Orr K. Schaffhauser H. Bezverkov RE. Aiyar J. Venkatraman S. Bioorg. Med. Chem. Lett.  2004,  14:  1913 
    Google Scholar
  • 8 Sashida H. Fujii A. Tsuchiya T. Chem. Pharm. Bull.  1987,  35:  3182 
    Google Scholar
  • 9 Smith KM. Miura M. Tabba HD. J. Org. Chem.  1983,  48:  4779 
    CrossrefGoogle Scholar
  • 10 Kumar KH. Peruma PT. J. Heterocycl. Chem.  2008,  45:  597 
    CrossrefGoogle Scholar
  • 11 Delfourne E. Darro F. Bontemps-Subielos N. Decaestecker C. Bastide J. Frydman A. Kiss R. J. Med. Chem.  2001,  44:  3275 
    CrossrefPubMedGoogle Scholar
  • 12 Ismail MM. Abass M. Hassan MM. Molecules  2000,  5:  1224 
    CrossrefGoogle Scholar
  • 14a Brahma S. Ray JK. J. Heterocycl. Chem.  2008,  45:  311 
    Google Scholar
  • 14b Brahma S. Ray JK. Tetrahedron Lett.  2005,  46:  6575 
    Google Scholar
  • 14c Becher J. Jorgensen PL. Pluta K. Krake NJ. Falt-Hansen B. J. Org. Chem.  1991,  57:  2127 
    Google Scholar
13

Experimental Procedure for the Synthesis of 4-Chloro-2-substituted Quinolines; 1,3-(2 H )-dicarbaldehyde 1o-r: To an ice-cold magnetically stirred solution of DMF (10 mL) and 2-arylquinoline (5.0 mmol), POCl3 (30 mmol, 2.8 mL) was added dropwise. The reaction mixture was heated to
50 ˚C for 3 h. After which it was poured into the crush ice, neutralized with sat. K2CO3 solution and extracted with EtOAc. After drying and condensation of the organic layer , the crude reaction product was purified by column chromatography using 5% EtOAc in PE as eluent to afford pure 1o-r.

15

General Procedure for the Synthesis of 2-Substituted Quinolines 2a-n: To a solution of DMSO (5 mL) and 4-chloro-N-formyl-1,2-dihydroquinolines 1a-n (1.0 mmol), NaN3 (1 mmol, 0.065 g) was added at r.t. The solution was then heated at the indicated temperature (90 ˚C or 120 ˚C or 150 ˚C) for the indicated time. After completion of the reaction (monitored by TLC) the mixture was treated with ice-water and extracted with EtOAc. The organic layer was washed with H2O, and then with brine. After condensation of the organic layer, the products 2a-n were obtained by column chromatography (PE-EtOAc).
2-(2-Chloro-6-fluorophenyl)quinoline (2f)
New compound. Yield: 99%; light yellow oil; R f 0.53 (PE-EtOAc, 5:1). ¹H NMR (400 MHz, CDCl3): δ = 8.27 (1 H, d, J = 8.0 Hz), 8.20 (1 H, d, J = 8.4 Hz), 7.89 (1 H, d, J = 8.0 Hz), 7.74-7.79 (1 H, m), 7.60 (1 H, t, J = 8.0 Hz), 7.50 (1 H, d, J = 8.0 Hz), 7.32-7.38 (2 H, m), 7.11-7.16 (1 H, m). ¹³C NMR (100 MHz, CDCl3): δ = 160.7 (d, ¹ J C-F = 248.7 Hz), 152.5, 147.9, 136.4, 134.3, 130.2 (d, ³ J C-F = 9.9 Hz), 129.8, 129.6, 127.6, 127.3, 127.1, 125.6 (d, 4 J C-F = 3.1 Hz), 123.0, 114.6 (d, ² J C-F = 22.0 Hz). HRMS (ESI): m/z [M + H]+ calcd for C15H10ClFN: 258.0408; found: 258.0477.

16

General Procedure for the Synthesis of 4-Substituted Isoxazolo[4,3- c ]quinolines-5-(4 H )-carbaldehyde 3o-r: To a solution of DMSO (5 mL) and 4-chloro-2-substituted quinolines-1,3 (2H)-dicarbaldehyde 1o-r (1.0 mmol), NaN3 (1.5 mmol, 0.098 g) was added at r.t. and the reaction mixture was kept at this temperature for 0.5 h. After completion of the reaction (monitored by TLC) the mixture was treated with ice-water and extracted with EtOAc. The organic layer was washed with H2O, and then with brine. After condensation of the organic layer, the products 3o-r were obtained by column chromatography (PE-EtOAc).
4-Phenylisoxazolo[4,3- c ]quinoline-5-(4 H )-carbaldehyde (3o)
New compound. Yield: 88%; white crystals; mp 176-178 ˚C; R f 0.46 (PE-EtOAc, 3:1). IR (KBr): 3121, 3057, 2851, 1677, 1609, 1574, 1475 cm-¹. ¹H NMR (400 MHz, DMSO): δ = 9.21 (1 H, s), 8.86 (1 H, s), 7.94 (1 H, d, J = 8.0 Hz), 7.73 (1 H, d, J = 8.0 Hz), 7.54-7.59 (1 H, m), 7.37-7.41 (1 H, m), 7.22-7.30 (3 H, m), 7.16 (2 H, d, J = 8.0 Hz), 7.10 (1 H, s). ¹³C NMR (100 MHz, DMSO): δ = 162.4, 156.0, 153.8, 138.8, 136.1, 132.2, 128.7, 127.8, 126.3, 126.1, 124.6, 121.2, 117.1, 114.7, 46.9. HRMS (EI): m/z [M+] calcd for C17H12N2O2: 276.0899; found: 276.0899.